Why Phoenix for Business?

FDA Tells Scottsdale-Based Maker of Zicam Cold Products to Stop - PhoenixCEOCFO.com

 

FDA Tells Scottsdale-Based Maker of Zicam Cold Products to Stop

Scottsdale-based Matrixx, Inc., the maker of the popular Zicam cold suppressant products, received a notice from the FDA that the company is in violation of a number federal drug laws, regarding the sale of three of its intranasal zinc-based products: Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Nasal Swabs and Zicam Cold Remedy Swabs (kids size). In addition, the FDA issued a warning to consumers to stop using the products because the products could cause a loss of the sense of smell (anosmia), either long-lasting or permanent.

In a strongly worded letter to the company, the FDA said that Matrixx's drugs do not fall under the exemption of most homeopathic products which makes the company in violation of numerous drug laws. According to the letter, the FDA noted that their investigation turned up 800 complaints about the products that the FDA did not know about. The company was given 15 days to respond to the notice.

The three products in question accounted for 40% of Matrixx's $100 million annual sales. On the news of the FDA action, the stock dropped on June 16 nearly 70 percent from $19.25 to $5.78. Over 34 million shares traded on the 16 and 17. Normally, the average daily volume was under 100,000 shares per day.

The company has been involved with a number of lawsuits, having settled one in 2006 for $12 million. Judging from the internet, a number of law firms are gearing up to file more lawsuits based on the FDA action.

The company has voluntarily pulled the products from the market and has placed large ads in a number of major newspapers, explaining the recall. The company plans to work with the FDA to show that its products are safe.

John Laub is the Chairman of the Phoenix CEO-CFO Group.

1. "Scottsdale-Based Zicam Faces Customer Lawsuit." Ken Alltucker The Arizona Republic. June 23, 2009.

2. "FDA Warning Stuns Scottsdale Company Matrixx. Report said Zicam Swabs, Gels Can Cause Loss of Smell." Ken Alltucker. The Arizona Republic. June 19, 2009.

3. "FDA: Zicam Nasal Sprays Harm Smell and Taste." Ken Alltucker and Ginger Rough. The Arizona Republic. June 17, 2009.

4. "Phoenix-based Makers of Zicam Settle Lawsuit Over Lost Sense of Smell." John Laub. CEO-CFO Group.com. April 20, 2006.

5. "FDA Advises Consumers Not To Use Certain Zicam Cold Remedies. Intranasal Zinc Product Linked to Loss of Sense of Smell." FDA News Release. June 16, 2009.

6. "Matrixx Initiatives, Inc. AKA Zicam LLC 6/16/09." Warning Letter.
Department of Health and Human Services Public Health Service. Food and Drug Administration. June 16, 2009.

Founding Sponsor

 

 

Platinum Sponsors

 

 


 

 


 

 


 

 

Gold Sponsors

 

Tatum

 


 

 


 

Expense Reduction Analysts

 

Community Sponsor

 

 

Founding Sponsor

 

 


 

Become A Sponsor

 

accram

 

Bios

 

Michael Swiszcz, President

 


 

John Laub, Chairman

 



Get Phoenix
CEO-CFO Group
Meeting Announcements
and Articles in
Your Inbox. Register for our newsletter.



SlamDunk
ASCPA, IMA & Phoenix CEO-CFO Group
4 Hour Ethics Seminar
4/23/10
Click here to register


IFRS vs GAAP Seminar 8/15/08
Click here to register
  © 2008 Phoenix CEO-CFO Group.
BannerView.com E-Business SolutionsGive your Website the BannerView.